Single Use Process for Production of AAV Gene Therapy Products

Logo
Presented by

Lance Marquardt at PTC Therapeutics, Vikas Gupta, at Repligen, Rachel Legmann at Repligen, and Gilbert Huang at Repligen

About this talk

An overview of single use manufacturing for the production of AAV gene therapy products with comparisons to traditional monoclonal antibody production.  Specific challenges of scaling up AAV production and considerations to accommodate a range of demands of differing gene therapy products will be discussed.  I will review the reasons for starting and the challenges of being the inhouse manufacturing facility for a rapidly growing company.  The challenges of making non-COVID products in the era of Warp Speed along with future commercial production comparing fully single use with a hybrid facility will be explored.

Related topics:

More from this channel

Upcoming talks (28)
On-demand talks (300)
Subscribers (29508)
BioPharma Webinars aims to keep its global audience abreast of all developments in the areas of Drug Development, Manufacturing, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality webinars, presented by the most respected people, working with companies in Pharmaceutical, Biopharmaceutical, Biologics and Biotech Industry.